Reaction vessel and use thereof

The reaction vessel, utilizing a microorganism's surface structure and lipid-sealed reaction spaces, addresses the challenge of preparing minute reaction spaces for digital measurement, improving detection sensitivity and quantitative performance in nucleic acid analysis.

WO2026235198A1PCT designated stage Publication Date: 2026-11-12RIKEN CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2026/017653
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-09
Filing Date
2026-05-08
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing technologies face challenges in easily preparing minute reaction spaces for digital measurement, which is crucial for enhancing detection sensitivity and quantitative performance in nucleic acid analysis.

Method used

A reaction vessel is created using a microorganism's surface structure, where the cell membrane is partially destroyed, allowing for the expression of membrane proteins, and filled with a liquid and sealed with a lipid membrane to form independent reaction spaces, utilizing CRISPR/Cas family proteins for nucleic acid detection.

Benefits of technology

This method enables easy preparation of uniform, minute reaction spaces for digital measurement, eliminating the need for external enzymes and reagents, and enhances detection sensitivity and quantitative performance in nucleic acid analysis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000021_0000
    Figure 00000021_0000
  • Figure 00000022_0000
    Figure 00000022_0000
  • Figure 00000023_0000
    Figure 00000023_0000
Patent Text Reader

Abstract

Provided are: a reaction vessel comprising a surface structure of a microorganism, wherein the microorganism has a surface structure including a cell membrane and a layer other than the cell membrane, and a part of the cell membrane has been destroyed; and a method for filling the reaction vessel with a liquid to seal the reaction vessel, said method comprising a step for bringing a liquid into contact with the reaction vessel to fill the interior of the reaction vessel with the liquid, and a step for bringing a lipid into contact with the reaction vessel filled with the liquid to form a lipid film and seal the reaction vessel.
Need to check novelty before this filing date? Find Prior Art

Description

Reaction vessel and use thereof

[0001] The present invention relates to a reaction vessel and use thereof. More specifically, the present invention relates to a reaction vessel composed of a surface layer structure of a microorganism, a method for producing the reaction vessel, a method for filling and sealing a liquid in the reaction vessel, and a method for detecting a target nucleic acid fragment in a sample. This application claims priority based on Japanese Patent Application No. 2025-078726 filed in Japan on May 9, 2025, the content of which is incorporated herein by reference.

[0002] As a technique for accurately detecting a target molecule in a sample, a technique of performing an enzymatic reaction in a large number of minute reaction spaces is known. These techniques are referred to as digital measurement. In digital measurement, a sample is divided into an extremely large number of minute reaction spaces to detect a signal.

[0003] Then, the signal from each reaction space is binarized, only the presence or absence of the target molecule is determined, and the number of molecules of the target molecule is counted. According to digital measurement, detection sensitivity and quantitative performance can be remarkably improved as compared with conventional ELISA, real-time PCR and the like. For example, Patent Documents 1 and 2 describe performing digital measurement in a minute reaction space.

[0004] Japanese Unexamined Patent Publication No. 2004-309405, Japanese Patent No. 7579577

[0005] The volume per reaction space used in digital measurement is 10 aL to 100 pL. Conventionally, as such reaction spaces, wells of well arrays produced by microfabrication technology and the like have been used. An object of the present invention is to provide a technique that allows minute reaction spaces to be easily prepared.

[0006] The present invention includes the following embodiments: [1] A reaction vessel comprising a surface structure of a microorganism, wherein the microorganism has a surface structure including a cell membrane and layers other than the cell membrane, and a part of the cell membrane is destroyed. [2] The reaction vessel according to [1], wherein the microorganism expresses a desired membrane protein, and the reaction vessel comprises the membrane protein. [3] The reaction vessel according to [2], wherein the membrane protein is a fusion protein of a desired protein and a membrane-binding domain. [4] A method for producing the reaction vessel according to any one of [1] to [3], comprising the step of contacting the microorganism with a surfactant. [5] A method for filling and sealing a reaction vessel with a liquid, comprising the steps of contacting the reaction vessel according to any one of [1] to [3] with a liquid to fill the inside of the reaction vessel with the liquid, and contacting the reaction vessel filled with the liquid with a lipid to form a lipid membrane and seal the reaction vessel. [6] A method for detecting a target nucleic acid fragment in a sample, comprising the steps of: (a) contacting the sample with a gRNA, a CRISPR / Cas family protein, and a substrate nucleic acid fragment complementary to the target nucleic acid fragment, wherein the CRISPR / Cas family protein expresses nuclease activity after forming a ternary complex with the gRNA and the target nucleic acid fragment, the substrate nucleic acid fragment is labeled with a fluorescent substance and a quenching substance, and when the fluorescent substance is cleaved by the nuclease activity of the ternary complex and separated from the quenching substance, it emits fluorescence upon irradiation with excitation light, the contact is performed in a reaction vessel according to any one of claims 1 to 3, and as a result, if the target nucleic acid fragment is present in the sample, the ternary complex is formed, the substrate nucleic acid fragment is cleaved, and the fluorescent substance separates from the quenching substance (a); and (b) irradiating the fluorescent substance with excitation light and detecting the fluorescence, wherein the detection of fluorescence indicates the presence of the target nucleic acid fragment in the sample. [7] The method according to [6], wherein the CRISPR / Cas family protein is a fusion protein with a membrane-binding domain and is expressed by the microorganism.

[0007] According to the present invention, it is possible to provide a technology that can easily prepare a minute reaction space.

[0008] Figure 1 is a schematic diagram illustrating the manufacturing method of the reaction vessel. Figure 2 is a schematic diagram illustrating the method of filling the reaction vessel with liquid and sealing it. Figure 3 is a schematic diagram illustrating the method of detecting the target nucleic acid fragment in the sample. Figure 4 is a microscopic image showing the results of Experimental Example 1. Figure 5 is a microscopic image showing the results of Experimental Example 2. Figure 6 is a microscopic image showing the results of Experimental Example 3. Figure 7 is a microscopic image showing the results of Experimental Example 4. Figure 8 is a microscopic image showing the results of Experimental Example 5. Figure 9 is a microscopic image showing the results of Experimental Example 6.

[0009] The embodiments of the present invention will be described in detail below, with reference to the drawings as appropriate. In the drawings, the same or corresponding parts are denoted by the same or corresponding reference numerals, and redundant explanations are omitted. Note that the dimensional ratios in each figure are exaggerated for illustrative purposes and do not necessarily correspond to the actual dimensional ratios.

[0010] [Reaction Vessel] In one embodiment, the present invention provides a reaction vessel comprising a surface structure of a microorganism, wherein the microorganism has a surface structure including a cell membrane and layers other than the cell membrane, and a part of the cell membrane is destroyed.

[0011] As will be described later in the examples, the reaction vessel of this embodiment makes it possible to easily prepare a minute reaction space.

[0012] The reaction vessel in this embodiment can also be described as the shell (empty shell structure) of a microbial organism. As the microorganism, one having a surface structure including a cell membrane (plasma membrane) and layers other than the cell membrane can be used. Examples of layers other than the cell membrane include a peptidoglycan layer and an S-layer.

[0013] As will be described later, the reaction vessel of this embodiment can be manufactured by destroying a portion of the cell membrane of a microorganism. Even if the cell membrane is destroyed, the structure of the reaction vessel is maintained by the support of layers other than the cell membrane. As will be described later, the reaction vessel of this embodiment can be filled with a desired liquid, sealed, and used to perform a desired assay.

[0014] In the reaction vessel of this embodiment, the cell membrane only needs to be broken down to the extent that it can be contained inside by passing the desired liquid through it.

[0015] In the reaction vessel of this embodiment, more specific examples of microorganisms include Gram-positive bacteria such as Bacillus subtilis, Staphylococcus aureus, Streptococcus, and Listeria monocytogenes; Gram-negative bacteria such as Escherichia coli, Pseudomonas aeruginosa, and Salmonella; halophilic bacteria; methanogens; and thermophilic archaea.

[0016] The volume of the reaction vessel in this embodiment varies depending on the microorganism used, but is approximately 10 a L to 100 p L. For example, if the microorganism is E. coli, the volume of the reaction vessel is approximately 1 f L. Since microorganisms naturally grow to a uniform size, the reaction vessel in this embodiment allows for the easy preparation of numerous reaction spaces of uniform size.

[0017] In the reaction vessel of this embodiment, the microorganism expresses a desired membrane protein, and the reaction vessel may contain the membrane protein.

[0018] In one embodiment, the desired membrane protein may be a membrane protein that is the subject of functional analysis, such as a drug efflux transporter or a flagellar apparatus.

[0019] As will be described later, the reaction vessel of this embodiment allows for free modification of the composition of the liquids inside and outside the vessel. For this reason, the reaction vessel of this embodiment can be suitably used to analyze the function of a desired membrane protein.

[0020] Alternatively, the membrane protein may be a fusion protein of the desired protein and a membrane-binding domain.

[0021] Here, the desired protein may be an enzyme used to perform the desired assay in the reaction space. More specifically, examples of desired proteins include CRISPR / Cas family proteins, alkaline phosphatases, β-galactosidases, nucleases, and the like.

[0022] A fusion protein of a desired protein and a membrane-binding domain can bind to the membrane of a microbial organism. Therefore, if a reaction vessel is prepared by disrupting a portion of the microbial cell membrane, the desired protein can be retained inside the reaction vessel.

[0023] Such reaction vessels do not require the addition of the desired protein (enzyme) from an external source and can be suitably used to perform the desired assay within the reaction vessel.

[0024] If the desired protein is a CRISPR / Cas family protein, the microorganism may also express gRNA. In this case, it is not necessary to add CRISPR / Cas family proteins and gRNA from outside in order to perform an assay using CRISPR / Cas family proteins in the reaction space, and the reaction vessel can be used suitably.

[0025] [Method for manufacturing a reaction vessel] In one embodiment, the present invention provides a method for manufacturing a reaction vessel as described above, comprising the step of contacting a microorganism with a surfactant.

[0026] Figure 1 is a schematic diagram illustrating the manufacturing method of this embodiment. The microorganism 100 has a cell membrane 110 and a surface structure 130 including a layer 120 other than the cell membrane. The specific microorganism is the same as described above. Cytoplasm 140 is present inside the cell membrane 110. When the surfactant is brought into contact with the microorganism 100, a part of the cell membrane 110 is destroyed, and the cytoplasm 140 is leached out and removed. Because the microorganism 100 has a layer 120, even if the cell membrane 110 is destroyed, the layer 120 remains and supports the structure, thereby maintaining the structure as a reaction vessel 100'. As a result, the reaction vessel described above is obtained. In the example of Figure 1, the microorganism 100 is fixed to the solid phase. However, the microorganism 100 does not have to be fixed to the solid phase.

[0027] As surfactants, anionic surfactants, nonionic surfactants, amphoteric surfactants, etc., can be used.

[0028] Examples of anionic surfactants include various fatty acid salts, alkylbenzene sulfonates, alkanesulfonates, alkyl sulfate esters, alkyl phosphate esters, polyoxyethylene alkyl ether sulfates, polyoxyethylene-substituted phenyl ether sulfates, and polycarboxylates. The counterions may be sodium, potassium, calcium, ammonium, triethanolamine, etc. More specifically, examples include sodium cholate and sodium dodecyl sulfate (SDS).

[0029] Examples of nonionic surfactants include fatty acid esters such as various higher fatty acid glycerols, polyoxyethylene alkyl ethers, polyoxypropylene alkyl ethers, polyoxyethylene fatty acid esters, fatty acid alkanolamides, alkyl glucosides, higher alcohols, Pluronic-type emulsifiers, and alkyldimethylamine-N-oxides. More specifically, examples include Triton X-100, Triton X-114, NP-40, Brij-35, Brij-58, Tween-20, Tween-80, octyl glucoside, and octyl thioglucoside.

[0030] Examples of amphoteric surfactants include alkylbetaine type amphoteric surfactants, amidebetaine type amphoteric surfactants, sulfobetaine type amphoteric surfactants, phosphobetaine type amphoteric surfactants, imidazolinium betaine type amphoteric surfactants, alkylamine oxide type amphoteric surfactants, amino acid type amphoteric surfactants, and phosphate ester type amphoteric surfactants. More specifically, examples include CHAPS and CHAPSO.

[0031] The surfactant concentration and reaction time can be adjusted as appropriate depending on the type of surfactant, the type of microorganism, etc. The surfactant concentration may be 1 to 1,000 times the critical micelle concentration (CMC). The reaction time (the time the surfactant is in contact with the microorganisms) may be 1 second to 10 minutes.

[0032] More specifically, for example, if the microorganism is E. coli and the surfactant is Triton X-100, the above-mentioned reaction vessel can be manufactured by reacting a surfactant at a concentration of 0.32% or higher (20 times that of CMC) for at least one minute.

[0033] [Method for filling and sealing a reaction vessel with liquid] In one embodiment, the present invention provides a method for filling and sealing a reaction vessel with liquid, comprising the steps of: bringing a liquid into contact with the reaction vessel described above to fill the inside of the reaction vessel with the liquid; and bringing a lipid into contact with the reaction vessel filled with the liquid to form a lipid film and seal the reaction vessel.

[0034] Figure 2 is a schematic diagram illustrating the method of this embodiment. When the liquid is brought into contact with the reaction vessel 100', the inside of the reaction vessel 100' is filled with the liquid. In the example of Figure 2, the liquid contains enzyme 200. When lipids are brought into contact with the reaction vessel 100' filled with liquid, the damaged cell membrane 110' is repaired, and a lipid membrane 110'' is formed. As a result, the reaction vessel 100' is sealed. In the example of Figure 2, the reaction vessel sealed by the lipid membrane 110'' is indicated by reference numeral 100''. In this way, the reaction vessel 100' can be filled with liquid and sealed.

[0035] Here, the reaction vessel 100' may be brought into contact with the liquid first, and then with the lipid. Here, it is preferable that the lipid is dissolved in the buffer. Alternatively, the liquid may contain lipids, and the reaction vessel 100' may be brought into contact with the lipid-containing liquid.

[0036] Each sealed reaction vessel 100'' becomes an independent reaction space. Furthermore, by replacing the liquid outside the reaction vessel 100'' with a desired liquid, the composition of the liquids inside and outside the reaction vessel can be freely modified.

[0037] In the example shown in Figure 2, a reaction by enzyme 200 takes place inside a reaction vessel 100'' sealed by a lipid membrane 110'', producing a reaction product. The reaction product may be, for example, a fluorescent substance. In this case, by irradiating the reaction vessel 100'' with excitation light and detecting the fluorescence with a fluorescence microscope or the like, it is possible to determine whether or not a reaction by enzyme 200 has occurred for each reaction vessel 100''. In other words, digital measurement can be performed.

[0038] [Method for detecting target nucleic acid fragments in a sample] In one embodiment, the present invention provides a method for detecting target nucleic acid fragments in a sample, comprising the steps of: (a) contacting the sample with a gRNA, a CRISPR / Cas family protein, and a substrate nucleic acid fragment complementary to the target nucleic acid fragment, wherein the CRISPR / Cas family protein expresses nuclease activity after forming a ternary complex with the gRNA and the target nucleic acid fragment; the substrate nucleic acid fragment is labeled with a fluorescent substance and a quenching substance, and when the fluorescent substance is cleaved by the nuclease activity of the ternary complex and separated from the quenching substance, it emits fluorescence upon irradiation with excitation light; the contact is performed in the reaction vessel described above, and as a result, if the target nucleic acid fragment is present in the sample, the ternary complex is formed, the substrate nucleic acid fragment is cleaved, and the fluorescent substance separates from the quenching substance (a); and (b) irradiating the fluorescent substance with excitation light and detecting the fluorescence, wherein the detection of fluorescence indicates the presence of the target nucleic acid fragment in the sample.

[0039] In recent years, Cas12 and Cas13, among the CRISPR / Cas family proteins that have been applied to genome editing, have been shown to form ternary complexes with gRNA and target nucleic acids, and to exhibit activity that cleaves surrounding DNA or RNA when the target nucleic acid is cleaved.

[0040] By utilizing this reaction, fluorescent substances can be generated using single-stranded or double-stranded nucleic acid fragments as target substances (target nucleic acids). Specifically, by using the Cas12 protein, double-stranded DNA fragments can be detected as target substances. Furthermore, by using the Cas13 protein, single-stranded RNA fragments or single-stranded DNA fragments can be detected as target substances.

[0041] Figure 3 is a schematic diagram illustrating this reaction. In Figure 3, the case where the CRISPR / Cas family protein is the Cas12a protein is used as an example.

[0042] First, as shown in the upper part of Figure 3, when Cas12a protein 310 and gRNA 320 are brought into contact, they bind together and form a binary complex 330. gRNA 320 has a base sequence that is complementary to the target nucleic acid fragment 340 (target substance) in part.

[0043] Next, when the target nucleic acid fragment 340 in the sample comes into contact with the binary complex 330, the Cas12a protein 310, gRNA 320, and target nucleic acid fragment 340 form a ternary complex 300. At this stage, the Cas12a protein 310 does not express nuclease activity, so the substrate nucleic acid fragment 350 is not cleaved. In the example in Figure 3, the substrate nucleic acid fragment 350 is a single-stranded DNA fragment labeled with fluorescent substance F and quenching substance Q. No fluorescence is generated even when the substrate nucleic acid fragment 350 is irradiated with excitation light.

[0044] When the ternary complex 300 is formed, the Cas12a protein 310 cleaves the target site of the target nucleic acid fragment 340. In the upper panel of Figure 3, the target site of the target nucleic acid fragment 340 is indicated by an arrowhead. The lower panel of Figure 3 is a schematic diagram showing the ternary complex 300' after the target site of the target nucleic acid fragment 340 has been cleaved. As shown in the lower panel of Figure 3, the ternary complex 300' exhibits nuclease activity. It then cleaves the substrate nucleic acid fragment 350 surrounding the ternary complex 300'. As a result, the fluorescent substance F of the substrate nucleic acid fragment 350 separates from the quenching substance Q. When the fluorescent substance F, separated from the quenching substance Q, is irradiated with excitation light, fluorescence can be detected. If fluorescence is detected, it can be determined that the target nucleic acid fragment 340 was present in the sample.

[0045] In the method of the present embodiment, the sample, the CRISPR / Cas family protein 310, the gRNA 320, and the substrate nucleic acid fragment 350 are brought into contact with each other inside the reaction vessel described above. This makes it possible to accommodate zero or one target nucleic acid fragment 340 in the sample per reaction space, and perform digital measurement.

[0046] Here, the sample, the CRISPR / Cas family protein 310, the gRNA 320, and the substrate nucleic acid fragment 350 may be mixed and brought into contact in any order.

[0047] For example, first, the CRISPR / Cas family protein 310 and the gRNA 320 may be brought into contact to preform the binary complex 330, and then the sample may be brought into contact. In this case, when the target nucleic acid fragment 340 is present in the sample, the target nucleic acid fragment 340 binds to the binary complex 330 to form the ternary complex 300. Thereafter, the substrate nucleic acid fragment 350 may be brought into contact.

[0048] Alternatively, after the binary complex 330 is formed, the target nucleic acid fragment 340 and the substrate nucleic acid fragment 350 may be brought into contact at the same time.

[0049] Alternatively, the CRISPR / Cas family protein 310, the gRNA 320, and the sample may be brought into contact at the same time. Also in this case, when the target nucleic acid fragment 340 is present in the sample, the ternary complex 300 is finally formed. Thereafter, the substrate nucleic acid fragment 350 may be brought into contact.

[0050] Alternatively, the sample, the CRISPR / Cas family protein 310, the gRNA 320, and the substrate nucleic acid fragment 350 may be brought into contact at the same time. Also in this case, when the target nucleic acid fragment 340 is present in the sample, the ternary complex 300 is finally formed. In the ternary complex 300, when the target site of the target nucleic acid fragment 340 is cleaved, the complex is converted into a ternary complex 300', which exhibits nuclease activity and cleaves the substrate nucleic acid fragment 350.

[0051] The CRISPR / Cas family proteins are fusion proteins with membrane-binding domains and may be expressed by the microorganism. In other words, the CRISPR / Cas family proteins may be pre-placed in the reaction vessel. Using such a reaction vessel eliminates the need to add the CRISPR / Cas family proteins from an external source. The gRNA may also be expressed by the microorganism. In this case, neither the CRISPR / Cas family proteins nor the gRNA need to be added from an external source.

[0052] Any CRISPR / Cas family protein that expresses nuclease activity after forming a ternary complex with gRNA and the target nucleic acid fragment can be used. More precisely, as described above, the CRISPR / Cas family protein expresses nuclease activity after forming a ternary complex and cleaving the target nucleic acid fragment.

[0053] Examples of such CRISPR / Cas family proteins include Cas12 protein and Cas13 protein. In this specification, Cas12 protein and Cas13 protein may refer to Cas12 protein, Cas13 protein, orthologues of these proteins, modified versions of these proteins, and the like.

[0054] More specific CRISPR / Cas family proteins that can be used in the method of this embodiment include, for example, Cas12a protein from Lachnospiracee bacterium ND2006 (LbCas12a, UniProtKB accession number: A0A182DWE3), Cas12a protein from Acidaminococcus sp. (AsCas12a, UniProtKB accession number: U2UMQ6), and Francisella tularensis subsp. Cas12a protein from Novicida (FnCas12a, UniProtKB accession number: A0Q7Q2), Cas12b protein from Alicyclobacillus acidoterrestris (AaCas12b, UniProtKB accession number: T0D7A2), Cas13a protein from Leptotricia wadei (LwaCas13a, NCBI accession number: WP_021746774.1), Lachnospiraceae bacterium Cas13a protein from NK4A179 (LbaCas13a, NCBI accession number: WP_022785443.1), Cas13a protein from Leptotricia buccalis C-1013-b (LbuCas13a, NCBI accession number: WP_015770004.1), Cas13b protein from Bergeyella zoohelcum (BzoCas13b, NCBI accession number: WP_002664492), Cas13b protein from Prevotella intermedia (PinCas13b, NCBI accession number: WP_036860899), Prevotella Cas13b protein from buccae (PbuCas13b, NCBI accession number: WP_004343973), Cas13b protein from Alistipes sp. ZOR0009 (AspCas13b, NCBI accession number: WP_047447901), Cas13b protein from Prevotella sp. MA2016 (PsmCas13b, NCBI accession number: WP_036929175),Cas13b protein from Riemerella anatipestifer (RanCas13b, NCBI accession number: WP_004919755), Cas13b protein from Prevotella aurantiaca (PauCas13b, NCBI accession number: WP_025000926), Cas13b protein from Prevotella saccharolistica (PsaCas13b, NCBI accession number: WP_051522484), Cas13b protein from Prevotella intermedia (Pin2Cas13b, NCBI accession number: WP_061868553), Capnocytophaga Cas13b protein from canimorsus (CcaCas13b, NCBI accession number: WP_013997271), Cas13b protein from Porphyromonas gulae (PguCas13b, NCBI accession number: WP_039434803), Prevotella sp. Cas13b protein from P5-125 (PspCas13b, NCBI accession number: WP_044065294), Cas13b protein from Porphyromonas gingivalis (PigCas13b, NCBI accession number: WP_053444417), Cas13b protein from Prevotella intermedia (Pin3Cas13b, NCBI accession number: WP_050955369), Csm6 protein from Enterococcus italicus (EiCsm6, NCBI accession number: WP_007208953.1), Lactobacillus Examples include the Csm6 protein derived from *Salivarius* (LsCsm6, NCBI accession number: WP_081509150.1) and the Csm6 protein derived from *Thermus thermophilus* (TtCsm6, NCBI accession number: WP_011229148.1).

[0055] In the method of this embodiment, the CRISPR / Cas family protein may be a mutant of the Cas family protein described above. As a mutant, for example, a mutant in which the nuclease activity after forming a ternary complex is increased can be used.

[0056] The substrate nucleic acid fragment is labeled with a fluorescent substance and a quenching substance. When the fluorescent substance is cleaved by the nuclease activity of the ternary complex and separated from the quenching substance, it emits fluorescence upon irradiation with excitation light.

[0057] The substrate nucleic acid fragment should be appropriately selected according to the substrate specificity of the CRISPR / Cas family protein being used. For example, the Cas12 protein cleaves single-stranded DNA as a substrate. Therefore, when using the Cas12 protein, it is best to use single-stranded DNA as the substrate nucleic acid fragment. Similarly, the Cas13 protein cleaves single-stranded RNA as a substrate. Therefore, when using the Cas13 protein, it is best to use single-stranded RNA as the substrate nucleic acid fragment.

[0058] The combination of fluorescent material and quenching material should be such that the fluorescence of the fluorescent material is quenched when they are placed in close proximity to each other. For example, when using FAM, HEX, etc. as the fluorescent material, Iowa Black FQ (IDT Corporation) can be used as the quenching material.

[0059] The present invention will now be described in more detail with reference to examples, but the present invention is not limited to the following examples.

[0060] [Experimental Example 1] (Reaction Vessel Production) A reaction vessel was produced by contacting microorganisms with a surfactant to destroy a portion of the cell membrane. E. coli expressing green fluorescent protein (GFP) was used as the microorganism. Triton X-100 was used as the surfactant. Under a fluorescence microscope, E. coli was contacted with 2 mM Triton X-100. Note that 2 mM is 10 times the critical micelle concentration (CMC) of Triton X-100.

[0061] Figures 4 (left and right) are superimposed images of fluorescence microscope images and differential interference contrast images. Figure 4 (left) is the image at the start of the experiment. GFP fluorescence was observed in the cytoplasm. Figure 4 (right) is the image one minute after contact with the surfactant. Part of the cell membrane was destroyed by the surfactant, causing the cytoplasm to leach out and the reaction vessel to be obtained. As the cytoplasm leached out, the GFP fluorescence disappeared. On the other hand, the shape of the E. coli was maintained as the cell wall remained intact.

[0062] [Experimental Example 2] (Filling and sealing of reaction vessel with liquid) The reaction vessel, prepared in the same manner as in Experimental Example 1, was filled with liquid and sealed. Tris buffer containing GFP was used as the liquid.

[0063] Figures 5 (left, center, and right) are superimposed images of fluorescence microscope images and differential interference contrast images. Figure 5 (left) shows the image at the start of the experiment. Figure 5 (center) shows the reaction vessel being in contact with Tris buffer containing GFP. Figure 5 (right) shows the reaction vessel being sealed after being in contact with Tris buffer containing GFP, and then further sealed by contacting it with Tris buffer containing lipid but without GFP. E. coli total lipid at 12.5 mg / mL was used as the lipid. As a result, it was confirmed that the reaction vessel could be filled with liquid by contacting it with a liquid, and that the reaction vessel could be sealed by further contacting it with a lipid.

[0064] [Experimental Example 3] (Sealing of the reaction vessel) The reaction vessel, prepared in the same manner as in Experimental Example 1, was sealed by contacting it with a lipid. As the lipid, fluorescently labeled lipid Fluorescein-DHPE (N-(Fluorescein-5-Thiocarbamoyl)-1,2-Dihexadecanoyl-sn-Glycero-3-Phosphoethanolamine, Triethylammonium Salt) was used. Fluorescein-DHPE was dissolved in HEPES buffer at 10 μg / mL before use.

[0065] Figures 6 (left, center, and right) are superimposed images of fluorescence microscope images and differential interference contrast images. Figure 6 (left) shows the image at the start of the experiment. Figure 6 (center) shows the reaction vessel in contact with Fluorescein-DHPE. In Figure 6 (center), the cells are observed to brighten, indicating lipid fusion. Figure 6 (right) shows the reaction vessel in contact with HEPES buffer after Fluorescein-DHPE has been added. Figure 6 (right) shows that the lipids do not detach from the cell membrane even when the liquid is replaced with HEPES buffer. From the above, it was confirmed that when lipids are brought into contact with the reaction vessel, the damaged cell membrane is repaired by the lipids, and the reaction vessel is sealed.

[0066] [Experimental Example 4] (Investigation of Surfactant Types) Reaction vessels were prepared by contacting microorganisms with various surfactants and destroying a portion of their cell membranes. E. coli expressing green fluorescent protein (GFP) was used as the microorganism. Anionic surfactants, nonionic surfactants, and amphoteric surfactants were used. Sodium cholate hydrate was used as the anionic surfactant at a concentration of 150 mM. Octyl glucoside was used as the nonionic surfactant at a concentration of 250 mM. CHAPS was used as the amphoteric surfactant at a concentration of 80 mM.

[0067] Figure 7 is an image obtained by superimposing fluorescence microscope images and differential interference contrast images. The upper panel of Figure 7 shows the image at the start of the experiment. GFP fluorescence was observed in the cytoplasm. The lower panel of Figure 7 shows the image 20 seconds after contact with the surfactant. Part of the cell membrane was destroyed by the surfactant, causing the cytoplasm to leach out and a reaction vessel to be obtained. As the cytoplasm leached out, the fluorescence of GFP disappeared. On the other hand, the shape of the E. coli was maintained as the cell wall remained intact. This demonstrates that a reaction vessel can be produced using any surfactant.

[0068] [Experimental Example 5] (Investigation of Surfactant Concentration) A reaction vessel was prepared in the same manner as in Experimental Example 4. As the microorganism, E. coli expressing green fluorescent protein (GFP) was used. As the surfactant, an amphoteric surfactant (CHAPS) was used at a concentration of 8 mM.

[0069] Figure 8 is an image created by superimposing fluorescence microscope images and differential interference contrast images. The top panel of Figure 8 shows the image at the start of the experiment. GFP fluorescence was observed in the cytoplasm. The middle panel of Figure 8 shows the image 20 seconds after contact with the surfactant. The bottom panel of Figure 8 shows the image 100 seconds after contact with the surfactant.

[0070] Comparison with Experimental Example 4 showed that the reaction vessel could be manufactured even with a lower surfactant concentration. However, a longer time was required for the manufacture of the reaction vessel.

[0071] [Experimental Example 6] (Enzyme reaction using a reaction vessel) A reaction vessel was prepared in the same manner as in Experimental Example 1 by contacting E. coli with a surfactant. Octyl glucoside was used as the surfactant. In addition, propidium iodide, a DNA-binding dye that is impermeable to cell membranes, was mixed with the surfactant solution at a concentration of 20 μM. Under a fluorescence microscope, E. coli was contacted with 25 mM octyl glucoside to obtain a reaction vessel.

[0072] Next, the resulting reaction vessel was brought into contact with a solution containing the lipid, enzyme, and substrate nucleic acid fragment, and sealed in the same manner as in Experimental Example 2. E. coli total lipid was used as the lipid. DNase was used as the enzyme. DNA labeled with a fluorescent substance and a quenching substance was used as the substrate nucleic acid fragment. Alexa 488 was used as the fluorescent substance, and Iowa Black FQ was used as the quenching substance. The lipid, enzyme, and quenching substance were dissolved in HEPES buffer before use.

[0073] Figure 9 is an image created by superimposing fluorescence microscope images and differential interference contrast images. The top row of Figure 9 shows the image at the start of the experiment. The second row from the top of Figure 9 shows the image immediately after contact with the surfactant. Part of the cell membrane was destroyed by the surfactant, and a reaction vessel was obtained. Because part of the cell membrane was destroyed, propidium iodide flowed into the cytoplasm, and fluorescence of intracellular genomic DNA was confirmed.

[0074] The third row from the top in Figure 9 shows the reaction vessel immediately after contacting the lipid, enzyme, and substrate nucleic acid fragment. The bottom row of Figure 9 shows the reaction vessel 60 seconds after contacting the lipid, enzyme, and substrate nucleic acid fragment (240 seconds after the start of the experiment). In the experiment in which 5 μg / mL of DNase was added as the enzyme, bright spots were observed inside the cells. This indicates that the substrate nucleic acid fragment was cleaved by DNase, and the distance between the fluorescent substance and the disappearing substance increased. In contrast, no bright spots were observed when no enzyme was added. From these results, it was confirmed that the enzymatic reaction can be carried out in the reaction vessel.

[0075] According to the present invention, it is possible to provide a technology that can easily prepare a minute reaction space.

[0076] 100...microorganism, 110...cell membrane, 120...layers other than the cell membrane, 130...surface structure, 140...cytoplasm, 100'...reaction vessel, 100''...sealed reaction vessel, 110''...lipid membrane, 200...enzyme, 300, 300'...ternary complex, 310...CRISPR / Cas family protein, 320...gRNA, 330...bitter complex, 340...target nucleic acid fragment, 350...substrate nucleic acid fragment, F...fluorescent substance, Q...quenching substance.

Claims

1. A reaction vessel comprising the surface structure of a microorganism, wherein the microorganism has a surface structure including a cell membrane and layers other than the cell membrane, and a portion of the cell membrane is destroyed.

2. The reaction vessel according to claim 1, wherein the microorganism expresses a desired membrane protein, and the reaction vessel contains the membrane protein.

3. The reaction vessel according to claim 2, wherein the membrane protein is a fusion protein of a desired protein and a membrane-binding domain.

4. A method for producing a reaction vessel according to any one of claims 1 to 3, comprising the step of contacting a microorganism with a surfactant.

5. A method for filling a reaction vessel with a liquid and sealing it, comprising the steps of: bringing a liquid into contact with a reaction vessel according to any one of claims 1 to 3, thereby filling the inside of the reaction vessel with the liquid; and bringing a lipid into contact with the reaction vessel filled with the liquid, thereby forming a lipid film and sealing the reaction vessel.

6. A method for detecting a target nucleic acid fragment in a sample, comprising the steps of: (a) contacting the sample with a gRNA, a CRISPR / Cas family protein, and a substrate nucleic acid fragment complementary to the target nucleic acid fragment, wherein the CRISPR / Cas family protein expresses nuclease activity after forming a ternary complex with the gRNA and the target nucleic acid fragment; the substrate nucleic acid fragment is labeled with a fluorescent substance and a quenching substance, and when the fluorescent substance is cleaved by the nuclease activity of the ternary complex and separated from the quenching substance, it emits fluorescence upon irradiation with excitation light; the contact is performed in a reaction vessel according to any one of claims 1 to 3, and as a result, if the target nucleic acid fragment is present in the sample, the ternary complex is formed, the substrate nucleic acid fragment is cleaved, and the fluorescent substance separates from the quenching substance (a); and (b) irradiating the fluorescent substance with excitation light and detecting the fluorescence, wherein the detection of fluorescence indicates the presence of the target nucleic acid fragment in the sample.

7. The method according to claim 6, wherein the CRISPR / Cas family protein is a fusion protein with a membrane-binding domain and is expressed by the microorganism.